These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 191534

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Specificity of rat xenogeneic cell-mediated cytolysis for the products of the K and D loci of the mouse H-2 complex.
    Burakoff SJ, Dorf ME, Benacerraf B.
    J Immunol; 1977 May; 118(5):1795-8. PubMed ID: 67147
    [Abstract] [Full Text] [Related]

  • 64. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS, Bonavida B.
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [Abstract] [Full Text] [Related]

  • 65. Cell-mediated cytotoxic reactions to tumor associated antigens.
    Herberman RB.
    J Reticuloendothel Soc; 1975 Apr; 17(4):236-40. PubMed ID: 50447
    [No Abstract] [Full Text] [Related]

  • 66. Non-T cell killing of mammary tumor cells by spleen cells: secretion of antibody and recruitment of cells.
    Blair PB, Lane MA.
    J Immunol; 1975 Jul; 115(1):184-9. PubMed ID: 168254
    [Abstract] [Full Text] [Related]

  • 67. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
    Treves AJ, Carnaud C, Trainin N, Feldman M, Cohen IR.
    Eur J Immunol; 1974 Nov; 4(11):722-7. PubMed ID: 4547711
    [No Abstract] [Full Text] [Related]

  • 68. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
    Kaneko Y, Oettgen HF, Obata Y, Nakayama E.
    Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
    [Abstract] [Full Text] [Related]

  • 69. Macrophage processing of antigen for induction of tumor immunity.
    Brunda MJ, Raffel S.
    Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Cytostasis against self-antigens.
    De Giorgi L, Matossian-Rogers A, Festenstein H.
    Clin Exp Immunol; 1978 Feb; 31(2):209-17. PubMed ID: 77201
    [Abstract] [Full Text] [Related]

  • 72. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC, Nunn ME, Park JY, Herberman RB.
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [Abstract] [Full Text] [Related]

  • 73. Cell surface components of carcinogen-induced lymphoid tumors in SJL/J mice.
    Haimovich J, Bergman Y, Linker-Israeli M, Haran-Ghera N.
    Eur J Immunol; 1977 Apr; 7(4):226-30. PubMed ID: 405224
    [Abstract] [Full Text] [Related]

  • 74. Induction of transplantation immunity by dansylated tumor cells.
    Hashimoto Y, Yamanoha B.
    Gan; 1976 Apr; 67(2):315-9. PubMed ID: 964559
    [Abstract] [Full Text] [Related]

  • 75. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor.
    Biddison WE, Palmer JC, Alexander MA, Cowan EP, Manson LA.
    J Immunol; 1977 Jun; 118(6):2243-53. PubMed ID: 68083
    [No Abstract] [Full Text] [Related]

  • 76. Dissociation between cytotoxic activity and delayed hypersensitivity against syngeneic or allogeneic tumor grafts.
    Sato M, Nomoto K, Yano Y, Taniguchi K, Takeya K.
    Gan; 1976 Dec; 67(6):835-47. PubMed ID: 1088135
    [Abstract] [Full Text] [Related]

  • 77. Primary in vitro sensitization of murine lymphocytes against isogeneic and allogeneic cells transformed by simian virus 40.
    Maki T, Howe ML.
    J Immunol; 1976 Oct; 117(4):1398-401. PubMed ID: 62000
    [Abstract] [Full Text] [Related]

  • 78. Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells.
    Forman J, Britton S.
    J Exp Med; 1973 Feb 01; 137(2):369-86. PubMed ID: 4539847
    [Abstract] [Full Text] [Related]

  • 79. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.
    Chesebro B, Wehrly K.
    J Exp Med; 1976 Jan 01; 143(1):85-99. PubMed ID: 1081583
    [Abstract] [Full Text] [Related]

  • 80. [Increase of the concentration of effector T-lymphocytes specific to antigens H2. 1. Elution of T-lymphocytes from the allogeneic target cells].
    Brondz BD, Egorova CG.
    Tsitologiia; 1976 Nov 01; 18(11):1387-92. PubMed ID: 70094
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.